Last reviewed · How we verify
Propofol : TCI Kataria
At a glance
| Generic name | Propofol : TCI Kataria |
|---|---|
| Sponsor | Pr Isabelle CONSTANT |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Bispectral Index Under Propofol Anesthesia in Children : a Study Between TIVA and TCI (NA)
- Remifentanil and Laryngeal Reflex Responses in Pediatric Patients With URI (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Propofol : TCI Kataria CI brief — competitive landscape report
- Propofol : TCI Kataria updates RSS · CI watch RSS
- Pr Isabelle CONSTANT portfolio CI